These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Severe pulmonary hypertension without significant pulmonary parenchymal disease in a pediatric patient with acquired immunodeficiency syndrome. Rhodes J; Schiller MS; Montoya CH; Fikrig S Clin Pediatr (Phila); 1992 Oct; 31(10):629-31. PubMed ID: 1395371 [No Abstract] [Full Text] [Related]
9. Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension. Cevik A; Kula S; Olguntürk R; Tunaoğlu S; Oğuz D; Saylan B; Sanlı C Anadolu Kardiyol Derg; 2014 Mar; 14(2):196-8. PubMed ID: 24566516 [No Abstract] [Full Text] [Related]
10. Fetal hypertension and the development of increased pulmonary vascular smooth muscle: a possible mechanism for persistent pulmonary hypertension of the newborn infant. Levin DL; Hyman AI; Heymann MA; Rudolph AM J Pediatr; 1978 Feb; 92(2):265-9. PubMed ID: 23421 [TBL] [Abstract][Full Text] [Related]
11. Inhalation of low-dose nitric oxide to evaluate pulmonary vascular reactivity in children with congenital heart disease. Yasuda T; Tauchi N; Baba R; Nishibata K; Hatano T; Nakamura S; Nagashima M Pediatr Cardiol; 1999; 20(4):278-82. PubMed ID: 10368453 [TBL] [Abstract][Full Text] [Related]
12. [Specificity and sensitivity of pulmonary valve motion in echocardiographic examination as an index of pulmonary hypertension]. Scarpini S; Brambilla R; Mazza P; Belli C; Weyman AE G Ital Cardiol; 1980; 10(10):1349-55. PubMed ID: 7239081 [TBL] [Abstract][Full Text] [Related]
13. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension. Day RW Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive detection of pulmonary hypertension in patent ductus arteriosus by pulsed Doppler echocardiography. Stevenson JG; Kawabori I; Guntheroth WG Circulation; 1979 Aug; 60(2):355-9. PubMed ID: 445753 [TBL] [Abstract][Full Text] [Related]
15. The assessment of pulmonary arterial pressures in bronchopulmonary dysplasia by cardiac catheterization and M-mode echocardiography. Newth CJ; Gow RM; Rowe RD Pediatr Pulmonol; 1985; 1(1):58-62. PubMed ID: 4058957 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Subhedar NV Acta Paediatr Suppl; 2004 Feb; 93(444):29-32. PubMed ID: 15035460 [TBL] [Abstract][Full Text] [Related]
17. Echocardiographic pitfalls in the diagnosis of pulmonary hypertension. Dolara A; Zuppiroli A; Cecchi F; Manetti A; Mazzuoli F; Santoro G Acta Cardiol; 1981; 36(6):451-3. PubMed ID: 6977959 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary vascular response of dogs with heartworm disease. Rawlings CA Can J Comp Med; 1978 Oct; 42(4):452-9. PubMed ID: 743600 [TBL] [Abstract][Full Text] [Related]
19. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response. Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]